Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C34H38Cl2FN3O4 |
Molecular Weight | 642.588 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1[C@H]([C@H](C2=C(F)C(Cl)=CC=C2)[C@]3(C(=O)NC4=C3C=CC(Cl)=C4)C15CCCCC5)C(=O)NC67CCC(CC6)(CC7)C(O)=O
InChI
InChIKey=YJCZPJQGFSSFOL-MNZPCBJKSA-N
InChI=1S/C34H38Cl2FN3O4/c1-2-40-27(28(41)39-32-16-13-31(14-17-32,15-18-32)30(43)44)25(21-7-6-8-23(36)26(21)37)34(33(40)11-4-3-5-12-33)22-10-9-20(35)19-24(22)38-29(34)42/h6-10,19,25,27H,2-5,11-18H2,1H3,(H,38,42)(H,39,41)(H,43,44)/t25-,27+,31?,32?,34+/m0/s1
Molecular Formula | C34H38Cl2FN3O4 |
Molecular Weight | 642.588 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:41:51 GMT 2023
by
admin
on
Sat Dec 16 11:41:51 GMT 2023
|
Record UNII |
15QAU0SI9J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
763020
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
||
|
FDA ORPHAN DRUG |
778720
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
||
|
FDA ORPHAN DRUG |
745620
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
||
|
FDA ORPHAN DRUG |
762520
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
||
|
FDA ORPHAN DRUG |
826021
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
||
|
FDA ORPHAN DRUG |
869522
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
||
|
FDA ORPHAN DRUG |
784720
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
91972012
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
PRIMARY | |||
|
C132991
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
PRIMARY | |||
|
1818393-16-6
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
PRIMARY | |||
|
300000039054
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
PRIMARY | |||
|
15QAU0SI9J
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
PRIMARY | |||
|
11788
Created by
admin on Sat Dec 16 11:41:51 GMT 2023 , Edited by admin on Sat Dec 16 11:41:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Blocks the MDM2−p53 interaction, liberates the tumor suppressor function of p53
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |